1. Department of cardiology, Hôpital Lariboisière, AP–HP, Inserm U-942, Université de Paris, 2, rue Ambroise-Paré, 75010 Paris, France;2. Mediterranean Association for research and studies in cardiology (MARS cardio), Centre for cardiovascular and nutrition research, AP–HM, Aix-Marseille University, INSERM 1263, INRA 1260, 13015 Marseille, France;3. Cardiology department, Hôpital Nord, 13015 Marseille, France;4. Mediterranean Association for research and studies in cardiology (MARS cardio), 13015 Marseille, France
Abstract:
Central illustration. Anti-thrombotic strategies in patients with acute coronary syndrome. ACS: acute coronary syndrome; ADP: adenosine diphosphate; CAD: coronary artery disease; CRP: C-reactive protein; IL-6; interleukin-6; DAPT: dual antiplatelet therapy; GRACE: Global Registry of Acute Coronary Events; NSTEMI: non-ST-segment elevation myocardial infarction; PAI-1: plasminogen activator inhibitor-1; PCI: percutaneous coronary intervention; PG12: prostaglandin 12; PPI: proton pump inhibitor; PRECISE-DAPT: PREdicting bleeding Complications in patients undergoing stent Implantation and SubsequEnt Dual AntiPlatelet Therapy; REACH: REduction of Atherothrombosis for Continued Health; STEMI: ST-segment elevation myocardial infarction; TIMI: Thrombolysis In Myocardial Infarction; Vwf: von Willebrand factor.